Medical Product Outsourcing

Surgical

Boston Scientific Closes Lumenis Surgical Biz Deal

Company gains laser systems, fibers, and accessories for urology and otolaryngology procedures.

PR Newswire 09.01.21

Cardiovascular

Boston Scientific Recalls INGENIO Pacemakers, CRT-Ps

Devices recalled due to risk of transition to safety mode.

U.S. Food and Drug Administration 08.12.21

Surgical

FDA OKs Boston Scientific's EXALT Model B Single-Use Bronchoscope

Designed for bedside procedures in the ICU and OR.

PR Newswire 08.10.21

Cardiovascular | Surgical

Boston Scientific Begins EkoSonic Endovascular System Study

Will compare interventional therapy with anticoagulation to anticoagulation alone for pulmonary embolism treatment.

PR Newswire 08.04.21

Boston Scientific

...

07.22.21

Boston Scientific Acquires Remaining Farapulse Shares

The $295 million deal complements company's electrophysiology portfolio to include the only commercially available cardiac pulsed field ablation technology.

Boston Scientific 06.24.21

Former Boston Scientific CEO Joins Xenter Board

Company began operations earlier this spring.

Business Wire 06.24.21

Diagnostics

Boston Scientific Receives CE Mark for Single-Use Bronchoscope

The EXALT Model B Bronchoscope is the latest device in the company’s single-use imaging portfolio.

Charles Sternberg, Assistant Editor 05.28.21

Surgical

Boston Scientific to Pay $189M to Settle Charges Over Surgical Mesh

The company misled consumers about its surgical mesh devices' safety and effectiveness.

Sam Brusco, Associate Editor 03.25.21

Chronic Disease

FDA Approves Boston Scientific's TheraSphere Y-90 Glass Microspheres

The only radioembolization treatment approved for U.S. patients with hepatocellular carcinoma.

Sam Brusco, Associate Editor 03.18.21

Surgical

Boston Scientific to Buy Lumenis' Surgical Biz for $1B

Gains laser systems, fibers, and accessories for urology and otolaryngology procedures.

Sam Brusco, Associate Editor 03.03.21

Neurological

Boston Scientific's Vercise Genus DBS Earns FDA Approval

Fourth-generation DBS portfolio features full-body MR conditional devices.

Sam Brusco, Associate Editor 01.22.21

Cardiovascular

Boston Scientific to Acquire Preventice for Up to $925M

Acquisition of external cardiac monitoring technologies, services provider to expand rhythm management diagnostics portfolio.

PR Newswire 01.21.21

Boston Scientific Sheds BTG Specialty Pharma Biz for $800M

Agreement includes the transfer of five facilities and approximately 280 employees globally.

PR Newswire 12.01.20

Cardiovascular | Surgical

Boston Scientific Recalls, Discontinues LOTUS Edge Aortic Valve

Voluntary recall is related solely to the delivery system.

PR Newswire 11.17.20

Cardiovascular

FDA Approves Boston Scientific's Ranger Drug-Coated Balloon

Drug-eluting stent and drug-coated balloon treats patients with peripheral artery disease.

PR Newswire 11.03.20

Cardiovascular | Surgical

Boston Scientific Launches Watchman FLX Study in Non-Valvular AFib Patients

Trial to study next-generation device as treatment alternative to NOACs.

PR Newswire 10.29.20

Neurological

Boston Scientific Launches Spinal Cord Stimulator Systems in Europe

Portfolio features full-body MRI conditional devices that combine therapy options for personalized pain relief.

PRNewswire 10.01.20

Cardiovascular

Boston Scientific Rolls Out ACCURATE neo2 in Europe

New Valve designed to reduce paravalvular leaking, improve procedural efficiency, and treat more patients with expanded indication over prior version.

PRNewswire 09.28.20

Cardiovascular

Boston Scientific Adds Heart Ablation System to Its Portfolio

Agreement with Farapulse expands company's access to pulsed field ablation technology.

PR Newswire 09.22.20

Neurological

Boston Scientific Launches Vercise Genus DBS System In Europe

Features full-body MRI conditional and Bluetooth capabilities across the portfolio.

PR Newswire 09.10.20

Cardiovascular | Surgical

Boston Scientific's Next-Generation WATCHMAN FLX LAAC Device Earns FDA Nod

New stroke risk reduction technology designed to advance procedural performance and safety.

PR Newswire 07.22.20

Boston Scientific

...

07.21.20

Cardiovascular

Boston Scientific's Insertable Cardiac Monitor System Cleared by FDA

Detects arrhythmias associated with heart conditions.

PRNewswire 06.29.20

Diagnostics

Boston Scientific Receives Medicare TPT Payment for Single-Use Duodenoscope

Helps ensure healthcare providers have access to Exalt Model D.

Boston Scientific 06.08.20

Minerva Surgical Acquires Boston Scientific Intrauterine Health Products

Combines the Minerva Endometrial Ablation System with the Genesys HTA Endometrial Ablation System.

PRNewswire 05.12.20

Molding

Vaupell Midwest Earns MedAccred Accreditation for Plastic Injection Molding

MedAccred is an oversight program designed to provide manufacturing supply-chain oversight for OEMs looking to partner with Contract Manufacturers.

Vaupell Midwest 04.16.20

Solving the Supply Chain: What Happens After COVID-19?

Join us on April 23rd as several members of the industry will discuss the impact the COVID-19 pandemic has had on the medical device manufacturing supply chain.

04.07.20

Cardiovascular | Surgical

Boston Scientific Recalls Imager II Angiographic Catheters

Catheter tip may detach during a procedure or preparation; nine reported injuries.

U.S. Food and Drug Administration 04.07.20

Digital Health

Digital Defenders: COVID-19 Creates a Spotlight on Digital Health Tools

Digital health tools like telemedicine, AI algorithms, and connectivity are playing an increasingly important role in helping prevent and manage disease.

Michael Barbella, Managing Editor 04.01.20

The Illusion of Choice in Healthcare

Consolidation hasn’t stopped for healthcare organizations and we can expect the number of decision makers to shrink as healthcare organizations become bigger.

Maria Shepherd, President and Founder, Medi-Vantage 04.01.20

Former Boston Scientific Marketing Director Joins CorWave Board

New board member also worked for Medtronic and Avedro.

Business Wire 04.01.20

Former Boston Scientific Exec Named DYSIS Medical Board Chairman

New leader also served on the boards of Clinical Innovations and Therakos.

Business Wire 03.25.20

Testing

The Importance of Usability/Human Factors Testing

When is the work of human factors over, and how does your team know they are prepared for summative testing?

Maria Shepherd, President and Founder, Medi-Vantage 03.04.20

Developing a Plan for Unplanned Crises

It is often assumed C-suite executives are well-trained for every situation and have all the answers, but life seldom adheres to a plan.

Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 03.04.20

415 CAPITAL Closes New Medtech Venture Capital Fund

The fund will invest in medical device companies in Europe, Israel and the United States.

Business Wire 02.25.20

Cardiovascular

Bardy Diagnostics Strengthens its Leadership Team

Company appoints COO and vice president of Regulatory Affairs & Quality Assurance.

PR Newswire 02.19.20

Cardiovascular

PQ Bypass Nearly Halfway Complete With DETOUR Trial

Connecticut doctor performs procedure on 100th patient in ongoing clinical study.

Business Wire 02.19.20

Re-Sterilization is Key to Capturing Global Duodenoscope Market Share

GlobalData expects positive growth in the sector over the next decade.

GlobalData 02.06.20

Digital Health

The Next Medtech Frontier: Digital Health and Home Healthcare

U.S. health systems want to find ways to reduce costs; however, the shift to treating patients at home instead of admitting them to a hospital is new.

Maria Shepherd, President and Founder, Medi-Vantage 01.29.20

Packaging & Sterilization